Development of a Breath Test for Monitoring Patients With Liver Disease

NCT00244569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Fatty Liver
Cirrhosis

Interventions

DRUG: 13C-Methacetin
DEVICE: Breath ID Machine

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]